Innovation in effective formulations is a key factor driving the artificial tears market, states Transparency Market Research in a report titled "Artificial Tears Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018." This comprehensive report studies the latest trends prevalent in the artificial tears market. It also identifies the major factors boosting and limiting the growth of the global market from 2012 to 2018. Backed by a number of tables and figures, the research study provides accurate market projections for the forecast period and also evaluates the impact of recent technological developments on the market.
Artificial tears are over-the-counter lubricant eye drops that are used to treat the irritation and dryness associated with various eye infections and diseases. Artificial tears contain salts, water, and polymers and are devoid of any proteins found in natural tears. Artificial tears in recent years have evolved to cater to patients who are required to use them more often than every three hours. For such patients, players within the market have developed artificial tears with no preservatives and those with non-irritating preservatives.
The most significant factor driving the artificial tears market is the rising incidence of dry eye syndrome (NYSEARCA:DES). Dry eye syndrome is triggered by a number of forces such as climatic changes and dry weather spells, alarming rise in pollution levels, malnutrition and poor dietary habits, frequent air travels, eye injury scars, poor eyelid closure, prolonged exposure to digital displays, and chronic conjunctivitis. Artificial tears serve as the first line of treatment for dry eye syndrome. The risk of contracting dry eye syndrome also increases with age. This means that the growing number of geriatrics around the world is also a significant factor driving the artificial tears market.
Other factors contributing towards the growth of the artificial tears market are rising preference for preservative-free artificial tears, ongoing technological advances, the need for proper management of dry eyes post eye surgery, rise in the number of smartphone addicts and mobile workforce, and surge in contact lens wearers.
One of the key features of the report on artificial tears market is its assessment of the vendor landscape. The major players are identified and evaluated based on parameters such as company overview, financial standing, products portfolio, and business strategies. With the help of a SWOT analysis, the report sheds the light on the strengths, weaknesses, opportunities, and threats of each player profiled in the report. Santen Pharmaceuticals Novartis International AG, Alcon, Inc., McNEIL-PPC, Inc., Bausch & Lomb, Advanced Vision Research, Inc., Abbott Medical Optics, and Allergan, Inc.
Browse Research Paper: http://www.transparencymarketresearch.com/artificial-tears-market.html